Jarrow Formulas' Vinpocetine Claim Cited In FDA "Courtesy" Letter
This article was originally published in The Tan Sheet
Jarrow Formulas' Vinpocetine 5 mg is cited by FDA in a Sept. 8 "courtesy" letter for making a structure/ function claim referring to "brain metabolism."
You may also be interested in...
Pharmavite's Nature Made line of nutritional supplements is expanding to include the first mass market product in the U.S. that contains vinpocetine as a stand-alone ingredient. A derivative of the periwinkle plant, the botanical is promoted as helping "improve memory and concentration."
A dietary supplement providing up to 20 mg of vincamine per day is reasonably expected to be safe when consumed by healthy adults for up to six months, FDA says in a letter to GNC recently made available by the agency.
General Nutrition Corporation plans to resubmit its new dietary ingredient premarket notification to FDA for a derivative of vinca minor (periwinkle) called vincamine.